SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
- 1 September 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 334 (1) , R1-R2
- https://doi.org/10.1016/s0014-2999(97)01160-6
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated miceEuropean Journal of Pharmacology, 1997
- Cannabinoid receptor stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding in rat brain membranesLife Sciences, 1996
- Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716Psychopharmacology, 1996